Preserving Timely Generic Drug Competition with Legislation on “Skinny Labeling”
Clinical Pharmacology & Therapeutics · 2024
DOI: 10.1002/cpt.3075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von S Sean Tu und 1 weiteren Autor:innen. Beteiligte Einrichtung: West Virginia University College of Law, Morgantown, West Virginia, USA. Hauptthemen laut MEDLINE: Drugs, Generic, Drug Industry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Patents prevent generic drug entry. Brand firms file new “method of use” patents for old drugs to prevent generic entry. Congress addressed this issue by creating the “skinny label” pathway, which allows generic firms to use the drug label to indicate that the old drug can only be used for non‐patented uses. This pathway is now in jeopardy due to a recent court case. This paper outlines the issues and suggests possible legislative solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- West Virginia University College of Law, Morgantown, West Virginia, USA.
- Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: S Sean Tu, Aaron S Kesselheim
Zitieren
APA
Tu, S. S., & Kesselheim, A. S. (2024). Preserving Timely Generic Drug Competition with Legislation on “Skinny Labeling”. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3075
Vancouver
Tu SS, Kesselheim AS. Preserving Timely Generic Drug Competition with Legislation on “Skinny Labeling”. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3075
BibTeX
@article{Tu2024,
author = {Tu, S Sean and Kesselheim, Aaron S},
title = {Preserving Timely Generic Drug Competition with Legislation on “Skinny Labeling”},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
doi = {10.1002/cpt.3075}
}
EUVIMED